Efficiency Gain and Early Toxicity Profile of Ultra—Versus Moderate-Hypofractionation: A Matched Real-World Comparison of the Two Current Standard Schedules for Adjuvant Breast Radiotherapy
Radiation · 02.11.2026 · 6 (4) · 43
DOI: 10.3390/radiation6040043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation, online erschienen am 02.11.2026. Verfasst von Angela Barillaro und 11 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ultra-hypofractionation (UHF) and moderate-hypofractionation (MHF) represent standard adjuvant radiotherapy (RT) schedules in breast cancer (BC). This study evaluates the departmental workflow impact and early physician-assessed toxicity kinetics of UHF compared to MHF in a matched real-world cohort.
Methods
Patients receiving UHF (26 Gy in 5 fractions ± simultaneous boost) during the first year of institutional adoption were matched 1:1 with historical MHF patients (40.05 Gy in 15 fractions ± sequential boost). Departmental workflow metrics and treatment delays were evaluated. Physician-graded acute toxicities (CTCAE v5.0) were recorded at treatment completion (Day 0), Day 10, and Day 50 post-RT.
Results
In total, 240 patients were analyzed. Transitioning to UHF coincided with enhanced efficiency, increasing adjuvant breast RT patient volume by 167% and reducing treatment delays (11% vs. 66%). UHF demonstrated lower G2 erythema at Day 0 (2% vs. 14%) and Day 10 (13% vs. 25%). Conversely, UHF exhibited higher G2 mastodynia (9% vs. 2%), oedema (10% vs. 3%) and G1 nipple–areola hyperpigmentation (NAC) (45% vs. 5%) at Day 10. Most acute toxicities were transient, becoming comparable between cohorts by Day 50.
Conclusions
Implementing UHF coincided with efficiency gain without compromising overall acute safety. However, findings necessitate prospective translational validation. Personalization of radiotherapy in breast cancer remains a cornerstone of modern cancer care.
Zitieren
APA
Barillaro, A., Caroprese, M., Goodyear, C. A., Chioccola, E., Valerio, G., Salzano, G., Oliviero, C., Clemente, S., Buono, M., Farella, A., Conson, M., & Pacelli, R. (2026). Efficiency Gain and Early Toxicity Profile of Ultra—Versus Moderate-Hypofractionation: A Matched Real-World Comparison of the Two Current Standard Schedules for Adjuvant Breast Radiotherapy. Radiation, 6(4), 43. https://doi.org/10.3390/radiation6040043
Vancouver
Barillaro A, Caroprese M, Goodyear CA, Chioccola E, Valerio G, Salzano G, et al. Efficiency Gain and Early Toxicity Profile of Ultra—Versus Moderate-Hypofractionation: A Matched Real-World Comparison of the Two Current Standard Schedules for Adjuvant Breast Radiotherapy. Radiation. 2026;6(4):43. doi:10.3390/radiation6040043
BibTeX
@article{Barillaro2026,
author = {Barillaro, Angela and Caroprese, Mara and Goodyear, Christina A. and Chioccola, Emanuele and Valerio, Gianluca and Salzano, Giuseppe and Oliviero, Caterina and Clemente, Stefania and Buono, Mauro and Farella, Antonio and Conson, Manuel and Pacelli, Roberto},
title = {Efficiency Gain and Early Toxicity Profile of Ultra—Versus Moderate-Hypofractionation: A Matched Real-World Comparison of the Two Current Standard Schedules for Adjuvant Breast Radiotherapy},
journal = {Radiation},
year = {2026},
volume = {6},
number = {4},
pages = {43},
doi = {10.3390/radiation6040043}
}
EUVIMED